A new animal study, presented at EuroPCR (17–20 May, Paris), indicates that a novel, fluoropolymer-coated, self-expanding, paclitaxel-eluting peripheral stent (Eluvia, Boston Scientific) is associated with significantly less neointima at 90 days than is a no polymer, paclitaxel-eluting peripheral stent (Zilver PTX, Cook Medical). Eluvia, which is CE marked but an investigational device in the USA, was also associated with more uniform neointimal coverage.
Vasorum has received approval of its premarket approval application from the US Food and Drug Administration (FDA). Celt ACD, which has received CE mark and is sold in Europe, is indicated for arterial puncture closure in both diagnostic and anticoagulated percutaneous interventional cardiology and radiology patients.
Positive twelve-month results from Intact Vascular’s Tack optimised balloon angioplasty—below-the-knee (TOBA-BTK) clinical study have been presented at the SCAI 2016 conference (4–7 May, Orlando, USA) by Christian Wissgott, assistant director at Westküstenklinikum Heide in Heide, Germany.
The background of the study is that historically, more advanced disease of the lower extremities has been most commonly treated with open surgical bypass. Although successful, this surgical approach is not without significant potential morbidity....
Twelve-month results from the MAJESTIC trial evaluating the performance of the Eluvia drug-eluting stent demonstrated a primary patency rate of 100% amongst diabetic patients and no target lesion revascularisations in this subgroup.
BOSTON -- Type 1 diabetes patients younger than 40 may be candidates for statin use, as guidelines recommend after age 40, researchers suggested.
Studies have shown an association between strict control of blood sugar and increased mortality. They have also suggested that a consequence of this control is low blood sugar (hypoglycemia), which may have adverse effects on the heart. In a new study, researchers examined the effects of hypoglycemia on cardiovascular autonomic control. They found that in their experimental model of hypoglycemia, there was a clear change in the body's responses to cardiovascular stress.
topic of vitamin D supplementation is a vast minefield of purported benefits - and lack thereof. Now, a new study suggests taking vitamin D supplements improves exercise performance and lowers the risk of heart disease.
Among three patients who had declined the glucocorticoids, clinicians often turn to first, IVIG monotherapy restored partial or full muscle strength and cut biomarkers of muscle damage as well, reported Andrew L. Mammen, MD, PhD, of the NIH in Bethesda, Md., and Eleni Tiniakou, MD, of Johns Hopkins University School of Medicine in Baltimore.
Midday naps are associated with reduced blood pressure levels and prescription of fewer antihypertensive medications, according to research presented at ESC Congress today by Dr Manolis Kallistratos, a cardiologist at Asklepieion Voula General Hospital in Athens, Greece.
NICE Endorses PICO negative pressure wound dressings for closed surgical incisions
Tack Endovascular System launches in USA, first commercial use announced
EVAR with an iliac branch endoprothesis is safe and effective
Medtronic revises IN.PACT post-market study data due to programming error, but conclusions remain the same
New DVT device completes first-in-human trial
Phone: (028) 3981 2678
Mobile: 0903 839 878 - 0909 384 389